Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance

Oncotarget (2016) - Comments
pubmed: 27835872 doi: 10.18632/oncotarget.13148 issn: 1949-2553

Tang Liu, Zhihong Li, Qing Zhang, Karen De Amorim De Amorim Bernstein, Santiago Lozano-Calderon, Edwin Choy, Francis J. Hornicek, Zhenfeng Duan